Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Omalizumab rapidly improves angioedema-related quality of life in adult patients with chronic spontaneous urticaria: X-ACT study data

Published:2017-12-11 Issue:3 Volume:73 Page:576-584
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Staubach P.¹,Metz M.²,Chapman-Rothe N.³,Sieder C.⁴,Bräutigam M.⁴,Maurer M.²^ORCID,Weller K.²^ORCID

Affiliation:

1. Department of Dermatology; University Medical Center Mainz; Mainz Germany

2. Department of Dermatology and Allergy; Charité - Universitätsmedizin Berlin; Berlin Germany

3. Novartis Pharma AG; Basel Switzerland

4. Novartis Pharma GmbH; Nuernberg Germany

Funder

Novartis Pharma

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/all.13339/fullpdf

Reference30 articles.

1. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update;Zuberbier;Allergy,2014

2. The urticarias: pathophysiology and management;Grattan;Clin Med,2012

3. An evidence based therapeutic approach to hereditary and acquired angioedema;Bork;Curr Opin Allergy Clin Immunol,2014

4. Effect of omalizumab on angioedema in H-antihistamine resistant chronic spontaneous urticaria patients: results from X-ACT, a randomised controlled trial;Staubach;Allergy,2016

5. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study;Maurer;Clin Exp Allergy,2017

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statement;International Journal of Dermatology;2024-07-04

2. Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient‐Oriented Outcomes and Urticaria and Angioedema;Journal of the European Academy of Dermatology and Venereology;2024-06-10

3. Real-world outcomes in patients with chronic spontaneous urticaria receiving omalizumab: insights from a clinical practice survey;Current Medical Research and Opinion;2024-06-02

4. Enhancing Patient-Reported Outcome Measures for Drug Hypersensitivity: A Validated 6-Item Quality-of-Life Questionnaire for Patients With Drug Hypersensitivity;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

5. Comparative efficacy and safety of the treatment by Omalizumab for chronic idiopathic urticaria in the general population: A systematic review and network meta‐analysis;Skin Research and Technology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3